NCT03125213View on ClinicalTrials.gov

A Study Evaluating AL-3778 in Combination With Peginterferon Alpha-2a in Chronic Hepatitis B Subjects

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 12, 2017

Primary Completion Date

February 15, 2019

Study Completion Date

February 15, 2019

Conditions
Hepatitis B, Chronic
Interventions
DRUG

AL-3778

AL-3778 tablets

DRUG

Peginterferon Alfa-2A

Peginterferon Alfa-2A for subcutaneous injection

DRUG

Placebo Oral Tablet

Placebo to Match AL-3778 tablet

Sponsors
All Listed Sponsors
lead

Alios Biopharma Inc.

INDUSTRY

NCT03125213 - A Study Evaluating AL-3778 in Combination With Peginterferon Alpha-2a in Chronic Hepatitis B Subjects | Biotech Hunter | Biotech Hunter